Molecular remission of chronic myelogenous leukemia (CML): Evidence for a graft-versus-leukemia (GVL) effect following non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).

被引：0
|
作者：
Childs, R [1 ]
Epperson, D [1 ]
Bahceci, E [1 ]
Clave, E [1 ]
van Rhee, F [1 ]
Jayasekara, D [1 ]
Barrett, J [1 ]
机构：
[1] NHLBI, Bone Marrow Transplant Unit, Hematol Branch, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4472
引用
收藏
页码：341B / 341B
页数：1
相关论文
共 50 条
  • [1] THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    MARMONT, AM
    LEUKEMIA & LYMPHOMA, 1993, 11 : 221 - 226
  • [2] Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant:: in vivo and in vitro evidence for a graft-versus-leukaemia effect
    Childs, R
    Epperson, D
    Bahceci, E
    Clave, E
    Barrett, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) : 396 - 400
  • [3] Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia.
    Sloand, EM
    Childs, RW
    Greene, A
    Phang, S
    Young, NS
    Barrett, J
    BLOOD, 2000, 96 (11) : 783A - 783A
  • [4] Non-Myeloablative Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia: Graft-Versus-Host Disease Potentiates Graft-Versus-Leukemia Effect and Improves Overall Survival
    Pizzola, Christopher J.
    Rakszawski, Kevin L.
    Ehmann, W. Christopher
    Rybka, Witold B.
    Wirk, Baldeep
    Naik, Seema
    Zheng, Hong
    Silar, Brook
    Mackey, Gina
    Mineishi, Shin
    Minagawa, Kentaro
    Claxton, David F.
    BLOOD, 2019, 134
  • [5] Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: Non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect
    Shimoni A.
    Giralt S.
    Khouri I.
    Champlin R.
    Current Oncology Reports, 2000, 2 (2) : 132 - 139
  • [6] Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martinez, B
    Cantú-Rodriguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    HAEMATOLOGICA, 2002, 87 (08) : 894 - 896
  • [7] Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes
    Martino, R
    Caballero, MD
    Simón, JAP
    Canals, C
    Solano, C
    Urbano-Ispízua, A
    Bargay, J
    Léon, A
    Sarrá, J
    Sanz, GF
    Moraleda, JM
    Brunet, S
    San Miguel, J
    Sierra, J
    BLOOD, 2002, 100 (06) : 2243 - 2245
  • [8] Graft-versus-leukemia (GVL) effect and immune tolerance after donor leukocyte infusions for recurrence of chronic myeloid leukemia (CML) post allogeneic blood and marrow transplant (BMT)
    Michallet, M
    Moullet, I
    Gebuhrer, L
    Javaux, F
    Charrin, C
    Gabert, J
    Archimbaud, E
    Fiere, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1343 - 1343
  • [9] Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis
    Slavin, S
    Nagler, A
    Varadi, G
    Or, R
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 853 - 857
  • [10] Delayed graft-versus-leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia
    Gutiérrez, A
    Solano, C
    Prósper, F
    Benet, I
    Sarsotti, E
    García-Conde, J
    HAEMATOLOGICA, 2000, 85 (03) : 330 - 332
12345